Trial Profile
Early Effects of PTH on the Proximal Femur.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Osteoporosis
- Focus Biomarker; Therapeutic Use
- 22 Nov 2016 Status changed from active, no longer recruiting to completed.
- 26 Feb 2016 Planned End Date changed from 1 May 2016 to 1 Mar 2016 as reported by ClinicalTrials.gov.
- 22 Feb 2016 Primary endpoint has been met. (Bone formation rate), as per an article published in the Journal of Clinical Endocrinology and Metabolism.